Abstract
Purpose
The polyamine analogue, N 1,N 11-diethylnorspermine (DENSpm), is currently being evaluated in clinical trials for the treatment of solid tumors. The response of solid tumors to this drug has been associated with superinduction of the polyamine catabolic enzyme, spermine/spermidine N 1-acetyltransferase (SSAT). Therefore, to estimate the response of breast cancers to DENSpm, we measured induction of SSAT in breast cancer explants treated in vitro with this polyamine analogue.
Experimental design
Expression of SSAT protein was evaluated by immunohistochemistry in tissue explants from 38 invasive breast cancer tumors incubated in vitro in the presence (or absence) of DENSpm. In addition, SSAT enzymatic activity was measured in tissue explants from four tumors with high cellularity.
Results
SSAT expression was significantly increased in 30 of 38 tumor samples treated with DENSpm compared to untreated controls. This induction of SSAT protein expression was found specifically in neoplastic cells of the treated samples, and was seen in all histologic patterns (ductal, lobular, and mucinous) of breast cancer examined. In tumor samples evaluated for changes in SSAT enzymatic activity, these changes correlated closely with changes in protein expression.
Conclusions
Immunohistochemical staining for induction of SSAT correlates with measures of enzymatic activity in a small sample where measurements were possible and suggests that immunohistochemistry may be used for predicting response of breast cancers to DENSpm. A high proportion of breast cancers induced SSAT in response to DENSpm, supporting the continued consideration of this class of agents for treatment of breast cancer.
Similar content being viewed by others
Abbreviations
- 5-FU:
-
5-fluorouracil
- DENSpm:
-
N 1,N 11-diethylnorspermine
- SSAT:
-
spermidine/spermine N 1-acetyltransferase
References
Bernacki RJ, Bergeron RJ, Porter CW (1992) Antitumor activity of N,N′-bis(ethyl)spermine homologues against human MALME-3 melanoma xenografts. Cancer Res 52:2424
Bernacki RJ, Oberman EJ, Seweryniak KE, Atwood A, Bergeron RJ, Porter CW (1995) Preclinical antitumor efficacy of the polyamine analogue N 1,N 11-diethylnorspermine administered by multiple injection or continuous infusion. Clin Cancer Res 1:847
Casero RA Jr, Pegg AE (1993) Spermidine/spermine N 1-acetyltransferase—the turning point in polyamine metabolism. FASEB J 7:653
Casero RA Jr, Celano P, Ervin SJ, Porter CW, Bergeron RJ, Libby PR (1989) Differential induction of spermidine/spermine N 1-acetyltransferase in human lung cancer cells by the bis(ethyl)polyamine analogues. Cancer Res 49:3829
Casero RA Jr, Celano P, Ervin SJ, Wiest L, Pegg AE (1990) High specific induction of spermidine/spermine N 1-acetyltransferase in a human large cell lung carcinoma. Biochem J 270:615
Casero RA Jr, Mank AR, Xiao L, Smith J, Bergeron RJ, Celano P (1992) Steady-state messenger RNA and activity correlates with sensitivity to N 1,Nc 12-bis(ethyl)spermine in human cell lines representing the major forms of lung cancer. Cancer Res 52:5359
Casero RA Jr, Gabrielson EW, Pegg AE (1994) Immunohistochemical staining of human spermidine/spermine N 1-acetyltransferase superinduced in response to treatment with antitumor polyamine analogues. Cancer Res 54:3955
Casero RA, Wang Y, Stewart TM, Devereux W, Hacker A, Smith R, Woster PM (2003) The role of polyamine catabolism in anti-tumour drug response. Biochem Soc Trans 31:361
Chang BK, Bergeron RJ, Porter CW, Vinson JR, Liang Y, Libby PR (1992) Regulatory and antiproliferative effects of N-alkylated polyamine analogues in human and hamster pancreatic adenocarcinoma cell lines. Cancer Chemother Pharmacol 30:183
Chen Y, Kramer DL, Diegelman P, Vujcic S, Porter CW (2001) Apoptotic signaling in polyamine analogue-treated SK-MEL-28 human melanoma cells. Cancer Res 61:6437
Coleman CS, Pegg AE (1997) Proteasomal degradation of spermidine/spermine N 1-acetyltransferase requires the carboxyl-terminal glutamic acid residues. J Biol Chem 272:12164
Coleman CS, Pegg AE (2001) Polyamine analogues inhibit the ubiquitination of spermidine/spermine N 1-acetyltransferase and prevent its targeting to the proteasome for degradation. Biochem J 358:137
Coleman CS, Huang H, Pegg AE (1995) Role of the carboxyl terminal MATEE sequence of spermidine/spermine N 1-acetyltransferase in the activity and stabilization by the polyamine analog N 1,N 12-bis(ethyl)spermine. Biochemistry 34:13423
Coleman CS, Huang H, Pegg AE (1996) Structure and critical residues at the active site of spermidine/spermine-N1-acetyltransferase. Biochem J 316:697
Davidson NE, Mank AR, Prestigiacomo LJ, Bergeron RJ, Casero RA Jr (1993) Growth inhibition of hormone-responsive and -resistant human breast cancer cells in culture by N 1,N 12-bis(ethyl)spermine. Cancer Res 53:2071
Davidson NE, Hahm HA, McCloskey DE, Woster PM, Casero RA Jr (1999) Clinical aspects of cell death in breast cancer: the polyamine pathway as a new target for treatment. Endocr Relat Cancer 6:69
Fogel-Petrovic M, Vujcic S, Brown PJ, Haddox MK, Porter CW (1996) Effects of polyamines, polyamine analogs, and inhibitors of protein synthesis on spermidine-spermine N 1-acetyltransferase gene expression. Biochemistry 35:14436
Fogel-Petrovic M, Vujcic S, Miller J, Porter CW (1996) Differential post-transcriptional control of ornithine decarboxylase and spermidine-spermine N 1-acetyltransferase by polyamines. FEBS Lett 391:89
Gabrielson EW, Pegg AE, Casero RA Jr (1999) The induction of spermidine/spermine N 1-acetyltransferase (SSAT) is a common event in the response of human primary non-small cell lung carcinomas to exposure to the new antitumor polyamine analogue N 1,N 11-bis(ethyl)norspermine. Clin Cancer Res 5:1638
Ha HC, Woster PM, Yager JD, Casero RA Jr (1997) The role of polyamine catabolism in polyamine analogue-induced programmed cell death. Proc Natl Acad Sci U S A 94:11557
Hahm HA, Dunn VR, Butash KA, Deveraux WL, Woster PM, Casero RA Jr, Davidson NE (2001) Combination of standard cytotoxic agents with polyamine analogues in the treatment of breast cancer cell lines. Clin Cancer Res 7:391
Hahm HA, Ettinger DS, Bowling K, Hoker B, Chen TL, Zabelina Y, Casero RA Jr (2002) Phase I study of N 1,N 11-diethylnorspermine in patients with non-small cell lung cancer. Clin Cancer Res 8:684
Marton LJ, Pegg AE (1995) Polyamines as targets for therapeutic intervention. Annu Rev Pharmacol Toxicol 35:55
Maxwell PJ, Longley DB, Latif T, Boyer J, Allen W, Lynch M, McDermott U, Harkin DP, Allegra CJ, Johnston PG (2003) Identification of 5-fluorouracil-inducible target genes using cDNA microarray profiling. Cancer Res 63:4602
McCloskey DE, Pegg AE (2000) Altered spermidine/spermine N 1-acetyltransferase activity as a mechanism of cellular resistance to bis(ethyl)polyamine analogues. J Biol Chem 275:28708
McCloskey DE, Coleman CS, Pegg AE (1999) Properties and regulation of human spermidine/spermine N 1-acetyltransferase stably expressed in Chinese hamster ovary cells. J Biol Chem 274:6175
Murray-Stewart T, Applegren NB, Devereux W, Hacker A, Smith R, Wang Y, Casero RA Jr (2003) Spermidine/spermine N 1-acetyltransferase (SSAT) activity in human small-cell lung carcinoma cells following transfection with a genomic SSAT construct. Biochem J 373:629
Porter CW, Bergeron RJ (1988) Enzyme regulation as an approach to interference with polyamine biosynthesis—an alternative to enzyme inhibition. Adv Enzyme Regul 27:57
Porter CW, Ganis B, Libby PR, Bergeron RJ (1991) Correlations between polyamine analogue-induced increases in spermidine/spermine N 1-acetyltransferase activity, polyamine pool depletion, and growth inhibition in human melanoma cell lines. Cancer Res 51:3715
Shappell NW, Miller JT, Bergeron RJ, Porter CW (1992) Differential effects of the spermine analog, N 1,N 12-bis(ethyl)-spermine, on polyamine metabolism and cell growth in human melanoma cell lines and melanocytes. Anticancer Res 12:1083
Shappell NW, Fogel-Petrovic MF, Porter CW (1993) Regulation of spermidine/spermine N 1-acetyltransferase by intracellular polyamine pools. Evidence for a functional role in polyamine homeostasis. FEBS Lett 321:179
Thomas T, Thomas TJ (2001) Polyamines in cell growth and cell death: molecular mechanisms and therapeutic applications. Cell Mol Life Sci 58:244
Vujcic S, Halmekyto M, Diegelman P, Gan G, Kramer DL, Janne J, Porter CW (2000) Effects of conditional overexpression of spermidine/spermine N 1-acetyltransferase on polyamine pool dynamics, cell growth, and sensitivity to polyamine analogs. J Biol Chem 275:38319
Wallace HM (2003) Polyamines and their role in human disease—an introduction. Biochem Soc Trans 31:354
Wallace HM, Caslake R (2001) Polyamines and colon cancer. Eur J Gastroenterol Hepatol 13:1033
Wallace HM, Duthie J, Evans DM, Lamond S, Nicoll KM, Heys SD (2000) Alterations in polyamine catabolic enzymes in human breast cancer tissue. Clin Cancer Res 6:3657
Wolff A, Armstrong DK, Fetting JH, Carducci MC, Riley CD, Bender JF, Casero RA, Davidson NE (2003) A phase II study of the polyamine analogue N 1,N 11-diethylnorspermine (DENSpm) daily of five days every 21 days in patients with previously treated metastatic breast cancer. Clin Cancer Res 9:5922
Xiao L, Casero RA Jr (1996) Differential transcription of the human spermidine/spermine N 1-acetyltransferase (SSAT) gene in human lung carcinoma cells. Biochem J 313:691
Acknowledgements
This paper was supported by National Institute of Health grants CA88843, CA51085, and CA98454.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gabrielson, E., Tully, E., Hacker, A. et al. Induction of spermidine/spermine N 1-acetyltransferase in breast cancer tissues treated with the polyamine analogue N 1,N 11-diethylnorspermine. Cancer Chemother Pharmacol 54, 122–126 (2004). https://doi.org/10.1007/s00280-004-0786-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00280-004-0786-1